Marcus Watkins

22PUBLICATIONS
154CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 19, 2026
Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma.

Grace Baek, Gaurav Varma, Samuel Yamshon

|Feb 09, 2026
Multiomic study of cutaneous T-cell lymphoma reveals single-cell clonal evolution in progression and therapy resistance.

Hannah K Dorando, Jared M Andrews, Oam U Khatavkar

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Sep 03, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies.

Suheil Albert Atallah-Yunes, Chijioke C Nze, Rebecca L King

|May 07, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.

Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal

|Dec 13, 2023
Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis.

Narendranath Epperla, Qiuhong Zhao, Tamara Moyo

Pageof 4

Frequent Collaborators

9 joint publications

Nancy L Bartlett

7 joint publications

David A Russler-Germain

6 joint publications

Brad S Kahl

5 joint publications

Neha Mehta-Shah